Table 4 Heart failure drug treatment on discharge, with analysis of age and gender effects and inpatient mortality
DrugWomenMenOR (95% CI) for menp ValueOR (95% CI) for age*p Value
No HF drug37 (1.0)42 (1.0)1.21 (0.76 to 1.91)0.4231.02 (1.00 to 1.05)0.030
Diuretic alone602 (15.8)441 (10.8)0.79 (0.69 to 0.91)0.0011.04 (1.03 to 1.05)<0.001
Diuretic3400 (89.1)3664 (89.5)1.08 (0.93 to 1.25)0.3181.01 (1.00 to 1.01)0.049
ACE/AIIRA2538 (66.5)3008 (73.4)1.21 (1.09 to 1.33)<0.0010.97 (0.97 to 0.98)<0.001
β-Blocker1195 (31.3)1537 (37.5)1.15 (1.04 to 1.27)<0.0010.98 (0.97 to 0.98)<0.001
Aldosterone antagonist915 (23.4)1256 (30.1)1.25 (1.13 to 1.39)<0.0010.98 (0.97 to 0.98)<0.001
Diuretic and ACE/AIIRA2349 (61.5)2793 (68.2)1.20 (1.09 to 1.32)<0.0010.98 (0.97 to 0.98)<0.001
All four drugs230 (6.0)438 (10.7)1.54 (1.30 to 1.83)<0.0010.96 (0.96 to 0.97)<0.001
Death729 (16.0)683 (14.3)1.13 (1.00, 1.27)0.0421.06 (1.05, 1.06)<0.001
  • AIIRA, angiotensin II receptor antagonist, HF, heart failure.

  • *OR per year of increasing age.